관류 시스템 시장 규모, 점유율, 성장률, 세계 산업 분석 : 유형별, 용도별, 지역별 인사이트, 예측(2026-2034년)

Growth Factors of perfusion systems Market

The global perfusion systems market is experiencing robust growth due to the increasing prevalence of chronic cardiovascular and respiratory diseases, rising organ transplantation procedures, and growing adoption of technologically advanced perfusion technologies. According to Fortune Business Insights, the market was valued at USD 5.45 billion in 2025 and is projected to grow from USD 5.97 billion in 2026 to USD 14.77 billion by 2034, registering a CAGR of 12.00% during the forecast period (2026-2034).

North America dominated the perfusion systems market in 2025, accounting for a 39.50% market share, supported by a high volume of cardiopulmonary procedures, strong healthcare infrastructure, and the presence of leading market players.

Market Drivers

Perfusion systems are medical devices that replicate the natural functioning of organs in a controlled environment and play a critical role during cardiac surgeries, organ transplantation, and extracorporeal circulation procedures. The rising incidence of non-communicable diseases (NCDs) such as cardiovascular disease, chronic lung disorders, and kidney failure is significantly increasing the number of cardiopulmonary bypass procedures globally.

Additionally, the growing geriatric population is a key contributor to market growth. For instance, China's population aged 65 years reached 203.4 million in 2023, accounting for 14.3% of the total population, which is directly increasing the demand for advanced surgical interventions and perfusion support systems.

Market Trends

Increasing Adoption of Machine Perfusion

A key trend shaping the market is the shifting preference toward machine perfusion, particularly for organ preservation. Healthcare organizations and transplant centers are increasingly adopting hypothermic and normothermic machine perfusion techniques to improve organ viability and reduce post-transplant rejection rates.

According to the 2023 Scientific Registry of Transplant Recipients, the adoption of machine perfusion for donation after circulatory death (DCD) organs increased significantly, reaching around 60% by July 2023. This trend is accelerating research activities and product development in isolated organ perfusion systems.

Market Segmentation Analysis

By Product Type

Based on product type, the market is segmented into cardiopulmonary perfusion systems, extracorporeal membrane oxygenation (ECMO), and isolated organ perfusion systems.

• Cardiopulmonary perfusion systems dominated the market in 2026, holding a 76.57% share, driven by the high volume of heart and lung surgeries and transplant procedures.
• The ECMO segment is expected to grow steadily due to the rising number of ECMO centers worldwide.
• Isolated organ perfusion systems are projected to grow at the fastest rate, supported by increasing R&D efforts and adoption of ex-vivo organ preservation technologies.

By Age Group

• The adult segment accounted for 58.42% market share in 2026, driven by a high prevalence of cardiovascular disorders and organ failures.
• The pediatric segment is expected to grow at a significant CAGR due to increasing congenital heart disorders and pediatric transplant procedures.

By End User

• Hospitals & ASCs dominated the market in 2026 with a 45.60% share, owing to higher procedure volumes and availability of advanced infrastructure.
• Specialty clinics and research institutes are expected to witness steady growth due to rising specialization and increased clinical research activities.

Regional Insights

• North America: Valued at USD 2.16 billion in 2025, driven by rising cardiac surgeries and strong product innovation. The U.S. market is projected to reach USD 2.20 billion by 2026.
• Europe: Growth supported by increasing transplant procedures in Germany and France and improving organ donation frameworks.
• Asia Pacific: Expected to register the highest CAGR, driven by a growing elderly population and rising chronic disease burden in China, Japan, and India.
• Latin America & Middle East & Africa: Moderate growth due to improving healthcare infrastructure and rising awareness initiatives.

Competitive Landscape

The market is semi-consolidated, with major players such as LivaNova PLC, Getinge, Medtronic, XVIVO, and TransMedics holding a significant share. These companies are focusing on product launches, regulatory approvals, and R&D investments to strengthen their global presence.

Conclusion

The global perfusion systems market is poised for strong growth through 2034, driven by rising cardiopulmonary procedures, increasing organ transplantation, and technological advancements in machine perfusion systems. With the market expected to reach USD 14.77 billion by 2034, continuous innovation, expanding healthcare access, and growing awareness of advanced perfusion technologies will remain key growth enablers. Despite cost-related challenges in emerging economies, sustained investments by key players and supportive government initiatives are expected to strengthen market adoption worldwide.

Segmentation By Product Type

• Cardiopulmonary Perfusion Systems
  • Oxygenation Systems
  • Heart-Lung Machines
  • Cooling and Heating Devices
  • Blood Parameter Monitoring Systems
  • Centrifugal Blood Pump Systems
  • Others
• Extracorporeal Membrane Oxygenation (ECMO)
• Isolated Organ Perfusion Systems

By Age Group

• Adults
• Pediatrics

By End User

• Hospitals & ASCs
• Specialty Clinics
• Others

By Region

• North America (By Product Type, By Age Group, By End User, By Country)
  • U.S.
  • Canada
• Europe (By Product Type, By Age Group, By End User, By Country/Sub-region)
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Product Type, By Age Group, By End User, By Country/Sub-region)
  • China
  • India
  • Japan
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Product Type, By Age Group, By End User, By Country/Sub-region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Product Type, By Age Group, By End User, By Country/Sub-region)
  • GCC
  • South Africa
  • Rest of the Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence of Key Cardiovascular Diseases - Key Countries, 2025
• 4.2. Number of Major Organ Transplantations, By Key Countries, 2025
• 4.3. Pricing Analysis, Key Products, Key Countries/Regions
• 4.4. New Product Launches, Key Players
• 4.5. Key Industry Developments - Mergers, Acquisitions & Partnerships
• 4.6. Impact of COVID-19 on the Market

5. Global Perfusion Systems Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Product Type
  • 5.1.1. Cardiopulmonary Perfusion Systems
    • 5.1.1.1. Oxygenation Systems
    • 5.1.1.2. Heart-lung Machines
    • 5.1.1.3. Cooling and Heating Devices
    • 5.1.1.4. Blood Parameter Monitoring Systems
    • 5.1.1.5. Centrifugal Blood Pump Systems
    • 5.1.1.6. Others
  • 5.1.2. Extracorporeal Membrane Oxygenation (ECMO)
  • 5.1.3. Isolated Organ Perfusion Systems
• 5.2. Market Analysis, Insights and Forecast - By Age Group
  • 5.2.1. Adults
  • 5.2.2. Pediatrics
• 5.3. Market Analysis, Insights and Forecast - By End User
  • 5.3.1. Hospitals & ASCs
  • 5.3.2. Specialty Clinics
  • 5.3.3. Others
• 5.4. Market Analysis, Insights and Forecast - By Region
  • 5.4.1. North America
  • 5.4.2. Europe
  • 5.4.3. Asia Pacific
  • 5.4.4. Latin America
  • 5.4.5. Middle East & Africa

6. North America Perfusion Systems Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Product Type
  • 6.1.1. Cardiopulmonary Perfusion Systems
    • 6.1.1.1. Oxygenation Systems
    • 6.1.1.2. Heart-lung Machines
    • 6.1.1.3. Cooling and Heating Devices
    • 6.1.1.4. Blood Parameter Monitoring Systems
    • 6.1.1.5. Centrifugal Blood Pump Systems
    • 6.1.1.6. Others
  • 6.1.2. Extracorporeal Membrane Oxygenation (ECMO)
  • 6.1.3. Isolated Organ Perfusion Systems
• 6.2. Market Analysis, Insights and Forecast - By Age Group
  • 6.2.1. Adults
  • 6.2.2. Pediatrics
• 6.3. Market Analysis, Insights and Forecast - By End User
  • 6.3.1. Hospitals & ASCs
  • 6.3.2. Specialty Clinics
  • 6.3.3. Others
• 6.4. Market Analysis, Insights and Forecast - By Country
  • 6.4.1. U.S.
  • 6.4.2. Canada

7. Europe Perfusion Systems Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Product Type
  • 7.1.1. Cardiopulmonary Perfusion Systems
    • 7.1.1.1. Oxygenation Systems
    • 7.1.1.2. Heart-lung Machines
    • 7.1.1.3. Cooling and Heating Devices
    • 7.1.1.4. Blood Parameter Monitoring Systems
    • 7.1.1.5. Centrifugal Blood Pump Systems
    • 7.1.1.6. Others
  • 7.1.2. Extracorporeal Membrane Oxygenation (ECMO)
  • 7.1.3. Isolated Organ Perfusion Systems
• 7.2. Market Analysis, Insights and Forecast - By Age Group
  • 7.2.1. Adults
  • 7.2.2. Pediatrics
• 7.3. Market Analysis, Insights and Forecast - By End User
  • 7.3.1. Hospitals & ASCs
  • 7.3.2. Specialty Clinics
  • 7.3.3. Others
• 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 7.4.1. Germany
  • 7.4.2. U.K.
  • 7.4.3. France
  • 7.4.4. Spain
  • 7.4.5. Italy
  • 7.4.6. Scandinavia
  • 7.4.7. Rest of Europe

8. Asia Pacific Perfusion Systems Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Product Type
  • 8.1.1. Cardiopulmonary Perfusion Systems
    • 8.1.1.1. Oxygenation Systems
    • 8.1.1.2. Heart-lung Machines
    • 8.1.1.3. Cooling and Heating Devices
    • 8.1.1.4. Blood Parameter Monitoring Systems
    • 8.1.1.5. Centrifugal Blood Pump Systems
    • 8.1.1.6. Others
  • 8.1.2. Extracorporeal Membrane Oxygenation (ECMO)
  • 8.1.3. Isolated Organ Perfusion Systems
• 8.2. Market Analysis, Insights and Forecast - By Age Group
  • 8.2.1. Adults
  • 8.2.2. Pediatrics
• 8.3. Market Analysis, Insights and Forecast - By End User
  • 8.3.1. Hospitals & ASCs
  • 8.3.2. Specialty Clinics
  • 8.3.3. Others
• 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 8.4.1. Japan
  • 8.4.2. China
  • 8.4.3. India
  • 8.4.4. Australia
  • 8.4.5. Southeast Asia
  • 8.4.6. Rest of Asia Pacific

9. Latin America Perfusion Systems Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Product Type
  • 9.1.1. Cardiopulmonary Perfusion Systems
    • 9.1.1.1. Oxygenation Systems
    • 9.1.1.2. Heart-lung Machines
    • 9.1.1.3. Cooling and Heating Devices
    • 9.1.1.4. Blood Parameter Monitoring Systems
    • 9.1.1.5. Centrifugal Blood Pump Systems
    • 9.1.1.6. Others
  • 9.1.2. Extracorporeal Membrane Oxygenation (ECMO)
  • 9.1.3. Isolated Organ Perfusion Systems
• 9.2. Market Analysis, Insights and Forecast - By Age Group
  • 9.2.1. Adults
  • 9.2.2. Pediatrics
• 9.3. Market Analysis, Insights and Forecast - By End User
  • 9.3.1. Hospitals & ASCs
  • 9.3.2. Specialty Clinics
  • 9.3.3. Others
• 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 9.4.1. Brazil
  • 9.4.2. Mexico
  • 9.4.3. Rest of Latin America

10. Middle East & Africa Perfusion Systems Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Product Type
  • 10.1.1. Cardiopulmonary Perfusion Systems
    • 10.1.1.1. Oxygenation Systems
    • 10.1.1.2. Heart-lung Machines
    • 10.1.1.3. Cooling and Heating Devices
    • 10.1.1.4. Blood Parameter Monitoring Systems
    • 10.1.1.5. Centrifugal Blood Pump Systems
    • 10.1.1.6. Others
  • 10.1.2. Extracorporeal Membrane Oxygenation (ECMO)
  • 10.1.3. Isolated Organ Perfusion Systems
• 10.2. Market Analysis, Insights and Forecast - By Age Group
  • 10.2.1. Adults
  • 10.2.2. Pediatrics
• 10.3. Market Analysis, Insights and Forecast - By End User
  • 10.3.1. Hospitals & ASCs
  • 10.3.2. Specialty Clinics
  • 10.3.3. Others
• 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 10.4.1. GCC
  • 10.4.2. South Africa
  • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. Cardinal Health
    • 11.2.1.1. Overview
    • 11.2.1.2. Services
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. Financials (Based on Availability)
  • 11.2.2. Terumo Corporation
    • 11.2.2.1. Overview
    • 11.2.2.2. Services
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. Financials (Based on Availability)
  • 11.2.3. Medtronic
    • 11.2.3.1. Overview
    • 11.2.3.2. Services
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. Financials (Based on Availability)
  • 11.2.4. NIPRO
    • 11.2.4.1. Overview
    • 11.2.4.2. Services
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. Financials (Based on Availability)
  • 11.2.5. LivaNova PLC
    • 11.2.5.1. Overview
    • 11.2.5.2. Services
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. Financials (Based on Availability)
  • 11.2.6. Getinge
    • 11.2.6.1. Overview
    • 11.2.6.2. Services
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. Financials (Based on Availability)
  • 11.2.7. XVIVO
    • 11.2.7.1. Overview
    • 11.2.7.2. Services
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. Financials (Based on Availability)
  • 11.2.8. MicroPort Scientific Corporation
    • 11.2.8.1. Overview
    • 11.2.8.2. Services
    • 11.2.8.3. SWOT Analysis
    • 11.2.8.4. Recent Developments
    • 11.2.8.5. Strategies
    • 11.2.8.6. Financials (Based on Availability)
  • 11.2.9. TransMedics
    • 11.2.9.1. Overview
    • 11.2.9.2. Services
    • 11.2.9.3. SWOT Analysis
    • 11.2.9.4. Recent Developments
    • 11.2.9.5. Strategies
    • 11.2.9.6. Financials (Based on Availability)
  • 11.2.10. ECM Europe BV
    • 11.2.10.1. Overview
    • 11.2.10.2. Services
    • 11.2.10.3. SWOT Analysis
    • 11.2.10.4. Recent Developments
    • 11.2.10.5. Strategies
    • 11.2.10.6. Financials (Based on Availability)